FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q2 2022

SEC EDGAR SourceSEC Filings

Top Holdings315 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

3.7M$1.4B7.6%
Decreased

IQVIA HOLDINGS INC

3.2M$697.3M3.8%$145.73+46.93%
15 qtrssince 2018-Q4
Increased
60

THERMO FISHER SCIENTIFIC INC

1.2M$675M3.7%$395.98+34.00%
11 qtrssince 2019-Q4
Increased
59

TRANSUNION

7.5M$597M3.2%$92.47-15.36%
15 qtrssince 2018-Q4
Increased
69

BOSTON SCIENTIFIC CORP

15M$560.8M3.0%$38.48-1.76%
8 qtrssince 2020-Q3
Decreased
0

ARAMARK

16M$490.3M2.7%$24.80-14.81%
7 qtrssince 2020-Q4
Decreased
0

HOWMET AEROSPACE INC

13.8M$435.2M2.4%$28.78+7.89%
9 qtrssince 2020-Q2
Increased
54

ANTHEM INC

826,482$398.8M2.2%$291.80+58.23%
15 qtrssince 2018-Q4
Increased
58

CENTENE CORP

4.3M$367.3M2.0%$59.51+42.73%
10 qtrssince 2020-Q1
Increased
53

MASTERCARD INC - A

1.2M$363.2M2.0%$346.49-8.94%
6 qtrssince 2021-Q1
Increased
52
YMMYMM
ADR

FULL TRUCK ALLIANCE CO LTD

39.7M$359.5M1.9%$8.16-1.81%
5 qtrssince 2021-Q2
Increased
73

CLARIVATE PLC

24.6M$340.4M1.8%$15.06-6.15%
2 qtrssince 2022-Q1
Increased
79

WABTEC CORP

4M$327.5M1.8%$67.00+20.94%
15 qtrssince 2018-Q4
Decreased
0

MICROSOFT CORP

1.3M$326.9M1.8%$136.50+85.30%
15 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL C

143,407$313.7M1.7%$83.58+33.31%
15 qtrssince 2018-Q4
Decreased
0

DYNATRACE INC

7.8M$309.5M1.7%$41.510.00%
1 qtr
New
71
AZNAZN
ADR

ASTRAZENECA PLC

4.6M$305.9M1.7%$116.49+4.73%
4 qtrssince 2021-Q3
Increased
61

ACTIVISION BLIZZARD INC

3.9M$302.1M1.6%
2 qtrssince 2022-Q1
Increased
56

COSTAR GROUP INC

5M$299.8M1.6%$60.210.00%
1 qtr
New
71

EQUIFAX INC

1.6M$295.6M1.6%$195.38-10.09%
15 qtrssince 2018-Q4
Increased
63
$18.4B
AUM
315
Positions
Q2 2022
Filing
Rating · 1.5
Quarterly Portfolio Change
+21%Q1'21$20.1B+22%Q2'21$24.5B-13%Q3'21$21.4B-7%Q4'21$20B+3%Q1'22$20.7B-11%Q2'22$18.4B
Activity profile
$ moved · Q2'22
New22%Increased22%Decreased35%Exited20%
Composition
Equity vs derivatives
Equity92%Puts8%Calls0%
Holding period
Avg 1.1 years
<1Q7%1-4Q30%1-2Y48%2Y+15%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $18.4B across 315 positions as of Q2 2022. Top holdings: SPY (7.6%), IQV (3.8%), TMO (3.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q2 2022 Summary

Active quarter - 25 new positions, 30 exits, 49 increased. Top move: CLVT (INCREASED, conviction 79). Portfolio: $18.4B across 315 positions.

Top holdings by portfolio weight

Total AUM$17B
IQV3.78%
TMO3.66%
TRU3.24%
BSX3.04%
ARMK2.66%
HWM2.36%
ELV2.16%
CNC1.99%
MA1.97%
YMM1.95%
Other1.85%

Portfolio allocation by GICS sector

Sectors11
Healthcare33.05%
Unknown16.98%
Technology16.81%
Financial Services12.77%
Industrials10.01%
Communication Services5.15%
Real Estate3.05%
Basic Materials1.50%
Utilities0.40%
Energy0.28%
Other0.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used